当前位置:首页 - 行情中心 - 迪哲医药-U(688192) - 财务分析

迪哲医药-U

(688192)

  

流通市值:262.02亿  总市值:264.84亿
流通股本:4.60亿   总股本:4.65亿

迪哲医药-U(688192)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-5.83亿元,每股收益-1.32元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益144373.34万元,未分配利润-393946.89万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产295534.66万元,负债151161.32万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入586,301,134.9355,001,420.82159,641,464.34359,900,621.06
营业总成本1,234,483,936.24779,607,061.37382,021,501.251,356,850,887.84
其他经营收益
营业利润-582,901,080.21-378,990,328-193,740,729.91-941,301,044.88
利润总额-582,901,080.21-378,990,328-193,740,729.91-939,651,337.2
净利润-582,953,152.35-379,042,400.14-193,740,729.91-939,655,188.7
每股收益
其他综合收益----
综合收益总额-582,953,152.35-379,042,400.14-193,740,729.91-939,655,188.7
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,127,206,220.472,404,927,026.781,020,706,852.37998,972,803.78
非流动资产:
非流动资产合计828,140,402.04813,533,558.53784,132,605.39719,765,080.27
资产总计2,955,346,622.513,218,460,585.311,804,839,457.761,718,737,884.05
流动负债:
流动负债合计861,920,670.5888,200,263.76893,263,177.75785,084,502.82
非流动负债:
非流动负债合计649,692,509.71701,482,796.21888,042,173.06733,596,483.6
负债合计1,511,613,180.211,589,683,059.971,781,305,350.811,518,680,986.42
所有者权益(或股东权益):
归属于母公司股东权益合计1,440,437,716.451,624,158,702.7118,460,390.68193,755,800.4
股东权益合计1,443,733,442.31,628,777,525.3423,534,106.95200,056,897.63
负债和股东权益合计2,955,346,622.513,218,460,585.311,804,839,457.761,718,737,884.05
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计595,116,720.01382,022,208.42189,480,497.17485,100,641.45
经营活动现金流出小计1,019,173,567.99646,691,577.16321,147,456.631,135,626,105.72
经营活动产生的现金流量净额-424,056,847.98-264,669,368.74-131,666,959.46-650,525,464.27
投资活动产生的现金流量:
投资活动现金流入小计7,282,910,041.683,631,604,581.35732,182,713.484,018,911,576.93
投资活动现金流出小计7,734,943,303.924,148,832,364.76860,832,800.064,056,985,882.85
投资活动产生的现金流量净额-452,033,262.24-517,227,783.41-128,650,086.58-38,074,305.92
筹资活动产生的现金流量:
筹资活动现金流入小计2,333,585,746.052,333,585,746.05391,343,495.541,121,623,319.49
筹资活动现金流出小计692,677,328.45557,210,081.7128,726,444.47254,610,530.35
筹资活动产生的现金流量净额1,640,908,417.61,776,375,664.35262,617,051.07867,012,789.14
汇率变动对现金及现金等价物的影响-223,484.38-77,388.6341,823.67-2,449,850.28
现金及现金等价物净增加额764,594,823994,401,123.572,341,828.7175,963,168.67
期末现金及现金等价物余额1,014,484,565.631,244,290,866.2252,231,571.33249,889,742.63
补充资料:
现金及现金等价物的净增加额-994,401,123.57-175,963,168.67
最新报告期:2025-11-14
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券孙媛媛,杨希成,黄翰漾-1.62-0.351.132025-11-14
中金公司张琎,刘雅馨,朱言音-1.58-0.80--2025-11-04
TOP↑